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Abstract
Background: Few studies assessed effects of individual and multiple ions simultaneously on metabolic outcomes, due to
methodological limitation.
Methodology/Principal Findings: By combining advanced ionomics and mutual information, a quantifying measurement
for mutual dependence between two random variables, we investigated associations of ion modules/networks with
overweight/obesity, metabolic syndrome (MetS) and type 2 diabetes (T2DM) in 976 middle-aged Chinese men and women.
Fasting plasma ions were measured by inductively coupled plasma mass spectroscopy. Significant ion modules were
selected by mutual information to construct disease related ion networks. Plasma copper and phosphorus always ranked
the first two among three specific ion networks associated with overweight/obesity, MetS and T2DM. Comparing the
ranking of ion individually and in networks, three patterns were observed (1) ‘‘Individual ion,’’ such as potassium and
chrome, which tends to work alone; (2) ‘‘Module ion,’’ such as iron in T2DM, which tends to act in modules/network; and (3)
‘‘Module-individual ion,’’ such as copper in overweight/obesity, which seems to work equivalently in either way.
Conclusions: In conclusion, by using the novel approach of the ionomics strategy and the information theory, we observed
potential associations of ions individually or as modules/networks with metabolic disorders. Certainly, these findings need
to be confirmed in future biological studies.
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Introduction
Emerging evidence has suggested that ion homeostasis may play
important roles in the global epidemic trend of obesity and related
metabolic abnormalities, such as insulin resistance, metabolic
syndrome, and type 2 diabetes. Higher body iron (Fe) stores were
reported to predict hyperglycemia and type 2 diabetes by some
prospective studies [1,2,3], whereas higher serum magnesium (Mg)
levels were associated with lower risks of metabolic syndrome and
type 2 diabetes [4,5]. Moreover, higher dietary intakes of calcium
(Ca), Mg and zinc (Zn) were also related with lower incidence of
type 2 diabetes [6,7,8,9,10]. Meanwhile, data from intervention
study also demonstrated that Ca and Zn supplementation could
significantly improve fasting glucose levels and insulin resistance
[11,12]. However, most of the previous studies have focused on
the role(s) of single or a few ions simultaneously. Given delicate
homeostatic controlled nature, relationships of multi-ions are
extremely complicated with synergistic or antagonistic interactions
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to methodological limitation which could only estimate a few ions
at one time, it remains unclear whether a single ion alone or a
network of several ions affects metabolic outcomes in a different
manner. With recently advanced ionomic technology combining
with a mutual information approach which studies multiple ions
and their interactions globally as ion modules and/or ion
networks, we therefore are able to elucidate complicate associa-
tions of ions with metabolic abnormalities systematically.
In recent years, ‘‘omics’’ strategy in the combination with
complex multivariate statistical analysis has been extensively
applied to discriminate organic bimolecular and reveal biomarkers
or patterns in sampled subpopulations in a comparative quanti-
fication manner [15]. Introduced by Lahner and colleagues, the
term of ionome means the inclusion of all metals, metalloids, and
nonmetals presented in an organism [16], and has been extended
as metallome that includes biologically significant nonmetals such
as phosphorus (P), sulfur (S), selenium (Se) [17,18]. However, little
is known regarding to the information of the ionome so far
[19,20]. Because ionome involves such a broad range of important
biological processes, including electrophysiology (potassium [K],
sodium [Na]), signal transduction (Ca, Zn), enzymology (copper
[Cu], Zn, Se) and structural integrity (Zn, Fe), understanding of
the role(s) of ionomic profile and its association with metabolic
abnormality will provide novel mechanistic insights linking ion
homeostasis and metabolic consequences.
One of major challenges related with analysis of complicated
ion network is that traditional methods like principal component
analysis (PCA) which is usually based on linear dependences to
construct patterns for data with high dimension [21]. However,
the interaction among multiple ions might result in much more
complex relationships within ion modules/networks than simply
linear dependences [13,14]. To overcome this problem, we
applied mutual information in our analysis. Mutual information
is a measurement used to quantify the mutual dependence
between two random variables [22,23], and can be applied for
either linear or non-linear dependence [24,25]. This method has
been widely used in measuring the co-expression of genes for
microarray data analysis [26], and in applying machine learning
approaches of bioinformatics, such as feature selection [27]. It was
indicated by number of studies that mutual information was more
accurate than analysis of variance (ANOVA) and Kruskal-Wallis
test in detecting associations [28]. Therefore, by combining the
advanced ionomic with mutual information approach, we
systematically investigated the ionomic profile, represented by
ion modules and/or networks, and their associations with
overweight/obesity, metabolic syndrome and type 2 diabetes in
Chinese men and women.
Methods
Ethics Statement
The study was approved by the Institutional Review Board of
the Institute for Nutritional Sciences and written informed consent
was obtained from each participants.
Study Population and Sample Collection
This study used a population-based case-control sample
including 559 overweight/obese (body mass index
[BMI]$24.0 kg/m
2) and 500 age and sex matched normal-weight
(18#BMI,24.0 kg/m
2) individuals aged 35 to 54 years living in
Shanghai, China. The detail of the study was described in
elsewhere [29]. Home interviews were conducted by trained
health professionals and information on demographics, health
status and behaviors were collected through standardized ques-
tionnaires [29]. All participants were subsequently invited to take a
physical examination after overnight fasting in the local Centers
for Disease Control and Prevention (CDC) and community clinics.
Body weight, height, waist circumference, and blood pressure were
measured by a standardized protocol [29]. Individuals without
data of ion (n=83, 7.8%) were excluded and a total of 976
participants was included in the final analyses.
During the physical examination, fasting peripheral venous
blood was collected by a tube containing anticoagulant and then
centrifuged at 4uC, 3000 rpm for 15 min. All samples were
shipped in dry ice to the Institute for Nutritional Sciences and
stored at 280uC until analysis. Measurements of total cholesterol,
high-density lipoprotein (HDL) cholesterol, low-density lipoprotein
(LDL) cholesterol, triglycerides, glucose, C-reactive protein (CRP),
and interleukin-6 (IL-6) were described previously [29].
Metabolic syndrome was defined according to the updated
National Cholesterol Education Program-Adult Treatment Panel
III criteria for Asian-Americans [30], including at least 3 of the
following components: 1) Waist circumferences $90 cm in men or
$80 cm in women; 2) Triglycerides $1.7 mmol/l; 3) HDL
cholesterol ,1.03 mmol/l in men or ,1.30 mmol/l in women; 4)
Blood pressure $130/85 mmHg, or current use of anti-hyperten-
sive medications; and 5) Fasting plasma glucose (FPG)
$5.6 mmol/l. Type 2 diabetes was defined as FPG
$7.0 mmol/L or 2-h postload plasma glucose $11.1 mmol/l
during an oral glucose tolerance test (OGTT). OGTT was
conducted in 476 subjects with 5.5#FPG,7.0 mmol/l during the
physical examination. The selection procedure for OGTT was
described elsewhere [29].
Laboratory Measurements for ICP-MS Detection
Instrument and reagents. Agilent 7500cx inductively cou-
pled plasma mass spectroscopy (ICP-MS) system (Agilent Tech-
nologies, Tokyo, Japan) equipped with a G3160B I-AS integrated
autosampler was employed to measure ion profile. G3148B ISIS
system was also used to reduce detection time and volume of each
sample. Ni sample cone and skimmer cone were utilized with an
orifice diameter of 1.0 and 0.4 mm, respectively. Sample
introduction was performed with a micromist nebulizer combined
with a Scott-type double pass spray chamber (Agilent Technolo-
gies). The instrument was tuned to optimal conditions in terms of
sensitivity (Li, Y, Co, and Tl) and CeO/Ce and Ce
2+/Ce by using
a tuning solution (Agilent Technologies) containing 1 mg/L of Li,
Y, Tl, Ce and Co in 2% HNO3 (w/v). The determination was
operated in full quantitative mode, and typical operating
conditions used in this study were summarized in Table S1.
The internal standard containing Ge,
6Li, Lu, Rh, Tb, Sc, In,
and Bi (SPEX CertiPrep) was injected by peristaltic pump into the
ion source at an approximate concentration of 500 mg/L in the
online mode. The multi-element standard solution containing
aluminum (Al), arsenic (As), boron (B), barium (Ba), beryllium (Be),
bismuth (Bi), Ca, cadmium (Cd), cobalt (Co), chromium (Cr), Cu,
Fe, K, lithium (Li), Mg, manganese (Mn), molybdenum (Mo), Na,
nickel (Ni), P, lead (Pb), palladium (Pd), rhenium (Re), S, antimony
(Sb), Se, silicon (Si), stannum (Sn), strontium (Sr), vanadium (V),
titanium (Ti), wolfram (W) and Zn, each at a concentration of
1000 mg/mL (SPEX CertiPrep) were used. We detected 17
elements of them including Cr, Mn, Fe, Zn, Cu, Se, Mo, Sr, Sn,
Sb, Ti, Mg, Ca, P S, K, and Re. The standard curve included 0,
0.1, 1, 10, 100, 1000 and 10000 mg/L, respectively. Ultrapure
water (18.2 MV) was obtained from a water-purification system
(Sartorius, Arium 61316). Ultrapure grade HNO3 (100ppt, 65%
v/v, TAMA) was used in this study.
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centrifuge tube coated with PFA, to which 400 mL HNO3 was
added. The centrifuge tube was then placed into 150uC water bath
for 3 h until the solution became clear. The resulting solution was
diluted with ultrapure water to about 2 mL. The diluted samples
were stored at 4uC for ICP-MS analysis.
ICP-MS analytical validation. To test the validity of the
whole detection system, we determined concentrations of Na, Mg,
K, Ca, Fe, Cu, Zn, and Se in human serum (National Institute of
Quality Standards, Beijing, China, GBW09152) and compared
them with reference concentrations. Serum samples were pre-
treated and determined in the same procedure as described above
(Table S2). Moreover, the recovery test of 17 elements in human
plasma samples was repeated three times. At first, 17 elements
were quantified at their original concentrations. Then, the 20 mg/
L multi-element standard solution was added to random plasma
samples, and the spiked samples were assayed. Recoveries were
estimated using the formula: recovery (%) = ((amount found-
original amount)/(amount spiked)) 6 100% (Table S3). Addi-
tionally, the intra- and inter-day stability of the instrument was
assessed by analyzing concentrations of 17 elements in the quality
control sample of fetal bovine serum (Sijiqing Co. Ltd., Hangzhou,
China) added with 20 mg/L multi-element standard solution. We
detected quality control samples after each 10 plasma samples.
Moreover, concentrations of 17 elements in one human plasma
sample were detected 10 times in parallel to confirm the precision
of the method (Table S4).
Bioinformatics Analysis
Log-transformations were performed for all 17 ions to
approximate normality. Analysis of covariance for continuous
variables and logistic regression models for categorical variables
were applied for the comparison across different metabolic
outcomes.
All ion modules were tested to determine whether they were
associated with overweight/obesity, metabolic syndrome or type 2
diabetes based upon information theory. When computing the
conditional mutual information between ion module and disease
status, the following variables: for overweight/obesity, sex and age
were adjusted; for metabolic syndrome and type 2 diabetes, sex,
age and BMI were adjusted. Then the significant ion modules
were selected to construct relevant ion networks as following three
steps:
Table 1. Characteristics of participants according to obese status (n=976).
Normal-weight Overweight/Obesity
18#BMI,24 BMI$24 P value
N 460 516
Age (yrs)* 45.8 (5.5) 46.0 (5.3) 0.487
Men (n, %)* 149 (32.4) 207 (40.1) 0.012
Physical inactivity (n, %) 230 (50.0) 256 (49.6) 0.912
Education levels (n, %) 0.004
0,9 yrs 105 (22.8) 159 (30.8)
10,12 yrs 247 (53.7) 260 (50.4)
.12 yrs 108 (23.5) 97 (18.8)
Current smoker (yes, n, %) 97 (21.1) 137 (26.6) 0.687
Alcohol drinker (yes, n, %) 168 (36.5) 183 (35.5) 0.106
Family history of chronic diseases (n, %) 186 (40.4) 209 (40.5) 0.972
Metabolic syndrome (n, %) 43 (9.4) 356 (69.0) ,0.001
Type 2 diabetes (n, %) 26 (5.7) 96 (18.6) ,0.001
BMI (kg/m
2) 21.0 (1.4) 27.9 (2.6) ,0.001
Waist circumference (cm) 75.7 (6.1) 92.9 (7.8) ,0.001
Systolic blood pressure (mmHg) 118.0 (15.1) 130.5 (17.5) ,0.001
Diastolic blood pressure (mmHg) 74.4 (9.7) 83.7 (11.4) ,0.001
Glucose (mmol/l) 5.76 (1.05) 6.26 (1.49) ,0.001
Insulin (mU/ml){ 7.4 (7.0–7.7) 11.2 (10.8–11.7) ,0.001
HOMA-IR{ 0.85 (0.82–0.89) 1.31 (1.26–1.37) ,0.001
Total cholesterol (mmol/l) 5.14 (1.15) 5.30 (1.15) 0.020
LDL cholesterol (mmol/l) 3.12 (0.94) 3.40 (0.96) ,0.001
HDL cholesterol (mmol/l) 1.53 (0.44) 1.24 (0.34) ,0.001
Triglycerides (mmol/l){ 0.99 (0.94–1.04) 1.57 (1.49–1.65) ,0.001
CRP (mg/l){ 0.60 (0.55–0.65) 1.35 (1.24–1.46) ,0.001
IL-6 (pg/ml){ 1.19 (1.12–1.26) 1.66 (1.57–1.75) ,0.001
P value was calculated after adjustment for age and sex. Data are arithmetic mean (SD). Percentages may not sum to 100 because of rounding.
*Data not adjusted for itself.
{Data are geometric mean (95% CI).
doi:10.1371/journal.pone.0038845.t001
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Overweight/obesity Metabolic syndrome Type 2 diabetes
No (n=460) Yes (n=516) No (n=577) Yes (n=399) No (n=854) Yes (n=122)
Age (yrs)* 45.8 (5.5) 46.0 (5.3) 45.4 (5.5) 46.7 (5.1){ 45.9 (5.4) 46.2 (5.3)
Men (n, %)* 149 (32.4) 207 (40.1){ 188 (32.6) 168 (42.1){ 304 (35.6) 52 (42.6)
BMI (kg/m
2) 21.0 (1.4) 27.9 (2.6){ 22.6 (3.2) 27.6 (3.2){ 24.2 (3.9) 27.2 (4.0){
Ca (ppm){ 6.46 (6.39–6.54) 6.54 (6.46–6.62) 6.50 (6.44–6.58) 6.49 (6.40–6.59) 6.51 (6.45–6.57) 6.47 (6.33–6.62)
Cr (ppb){ 0.70 (0.49–0.99) 0.75 (0.54–1.04) 0.52 (0.38–0.72) 1.15 (0.81–1.64){ 0.66 (0.51–0.85) 1.42 (0.77–2.60){
Cu (ppb){ 629.7 (613.7–646.1) 657.3 (640.6–674.5){ 630.7 (616.2–645.6) 664.0 (644.9–683.7){ 639.4 (627.2–651.9) 678.0 (641.8–716.4){
Fe (ppb){ 818.5 (779.8–859.2) 910.2 (870.0–952.3){ 847.2 (810.9–885.1) 893.4 (849.2–939.8) 859.6 (829.2–891.2) 909.9 (837.9–988.1)
K (ppm){ 413.0 (403.0–423.2) 410.6 (401.4–420.0) 412.2 (403.3–421.3) 411.0 (400.6–421.6) 411.1 (403.8–418.5) 416.0 (398.0–434.8)
Mg (ppm){ 18.7 (18.5–18.8) 18.4 (18.3–18.6){ 18.6 (18.5–18.8) 18.4 (18.2–18.6){ 18.6 (18.5–18.8) 18.0 (17.6–18.4){
Mn (ppb){ 1.24 (1.04–1.49) 1.42 (1.23–1.64) 1.24 (1.06–1.44) 1.49 (1.26–1.76) 1.31 (1.16–1.48) 1.52 (1.15–2.01)
Mo (ppb){ 0.76 (0.62–0.94) 0.68 (0.55–0.82) 0.76 (0.63–0.90) 0.66 (0.52–0.84) 0.71 (0.61–0.83) 0.75 (0.51–1.09)
P (ppm){ 75.6 (74.4–76.7) 77.7 (76.6–78.8){ 74.9 (74.0–75.9) 79.3 (77.9–80.7){ 76.3 (75.5–77.2) 79.3 (76.8–81.8){
Re (ppb){ 0.07 (0.07–0.08) 0.08 (0.07–0.08) 0.07 (0.07–0.08) 0.07 (0.07–0.08) 0.08 (0.07–0.08) 0.07 (0.06–0.07){
S (ppm){ 1012.2 (1003.4–1021.1) 1029.1 (1019.7–1038.5){ 1015.2 (1007.3–1023.1) 1029.7 (1018.7–1040.8){ 1018.5 (1011.7–1025.4) 1039.4 (1020.2–1059.1){
Sb (ppb){ 0.50 (0.40–0.62) 0.38 (0.30–0.48) 0.40 (0.32–0.49) 0.49 (0.38–0.62) 0.42 (0.35–0.50) 0.55 (0.37–0.82)
Se (ppb){ 95.3 (93.7–96.9) 96.8 (95.1–98.4) 94.9 (93.4–96.4) 97.8 (95.9–99.7){ 95.6 (94.4–96.8) 99.5 (95.6–103.5){
Sn (ppb){ 0.91 (0.87–0.95) 0.93 (0.89–0.98) 0.90 (0.87–0.94) 0.95 (0.91–1.00) 0.93 (0.90–0.96) 0.89 (0.82–0.97)
Sr (ppb){ 32.3 (31.5–33.2) 34.0 (33.1–34.8){ 32.5 (31.7–33.2) 34.2 (33.2–35.3){ 33.2 (32.5–33.8) 33.2 (31.7–34.7)
Ti (ppb){ 139.8 (138.6–141.1) 140.4 (139.1–141.8) 139.8 (138.7–140.9) 140.6 (139.1–142.2) 139.9 (139.0–140.9) 141.5 (139.1–144.1)
Zn (ppb){ 389.6 (379.2–400.4) 404.7 (394.5–415.2) 393.8 (384.8–403.1) 402.9 (390.7–415.5) 397.5 (389.4–405.6) 398.1 (380.9–415.9)
Data are arithmetic mean (SD).
*Data not adjusted for itself.
{Data are geometric mean (95% CI).
{P value,0.05 between 2 groups after adjustment for age and sex. Percentages may not sum to 100 because of rounding.
doi:10.1371/journal.pone.0038845.t002
Table 3. Partial spearman correlation coefficients between ions and metabolic features and inflammatory markers (n=976).
Ca Cr Cu Fe K Mg Mn Mo P Re S Sb Se Sn Sr Ti Zn
Age* 20.06 0.15{ 0.14{ 0.081 20.02 0.071 0.05 0.19{ 0.25{ 20.11{ 0.03 0.18{ 0.15{ 0.11{ 0.02 0.04 20.13{
BMI 0.07 0.00 0.13{ 0.081 0.01 20.081 0.02 20.05 0.13{ 0.04 0.11{ 20.02 0.04 0.02 0.10{ 0.05 0.09{
Waist circumference 0.06 0.06 0.17{ 0.06 0.01 20.071 0.02 20.04 0.15{ 20.00 0.12{ 0.03 0.071 0.06 0.14{ 0.06 0.04
SBP 0.12{ 0.01 0.06 0.05 20.00 20.03 0.10{ 20.02 0.17{ 0.10{ 0.20{ 20.03 0.061 0.06 0.10{ 0.14{ 0.14{
DBP 0.11{ 0.071 0.10{ 0.05 0.01 20.01 0.13{ 20.00 0.19{ 0.081 0.19{ 0.01 0.081 0.09{ 0.12{ 0.15{ 0.14{
Glucose 20.18{ 0.16{ 0.13{ 20.04 20.00 20.15{ 20.01 0.00 0.02 20.25{ 20.04 0.13{ 0.03 20.04 20.02 20.12{ 20.19{
Insulin 0.01 0.10{ 0.16{ 20.01 0.04 20.061 20.081 0.071 0.20{ 20.05 0.15{ 0.09{ 0.15{ 0.05 0.02 0.04 20.03
HOMA-IR 20.00 0.11{ 0.17{ 20.01 0.04 20.071 20.081 0.071 0.21{ 20.06 0.15{ 0.10{ 0.16{ 0.05 0.02 0.03 20.04
Total cholesterol 20.13{ 0.08{ 0.14{ 0.03 0.01 20.03 20.00 0.00 0.37{ 20.19{ 20.01 0.071 0.17{ 20.02 20.02 20.071 20.10{
LDL cholesterol 20.08{ 0.071 0.16{ 0.04 0.01 20.01 20.00 20.01 0.32{ 20.13{ 0.02 0.06 0.17{ 20.00 0.00 20.04 20.05
HDL cholesterol 20.16{ 0.01 20.06 0.00 20.01 20.03 0.02 0.01 0.03 20.13{ 20.15{ 0.04 0.00 20.05 20.081 20.12{ 20.16{
Triglycerides 20.02 0.14{ 0.19{ 0.01 20.03 20.02 0.01 0.05 0.40{ 20.13{ 0.12{ 0.10{ 0.13{ 0.05 0.09{ 0.04 20.01
CRP 0.04 0.071 0.42{ 20.081 20.04 20.05 0.04 20.01 0.16{ 20.02 0.06 0.04 0.071 0.08{ 0.11{ 0.05 20.05
IL-6 0.071 0.05 0.31{ 20.06 20.06 20.00 0.01 20.03 0.10{ 20.01 0.071 0.01 0.00 0.06 0.13{ 0.081 20.01
All correlation coefficients were calculated after adjustment for age and sex.
*Data not adjusted for itself.
{P,0.001,
{P,0.01,
1P,0.05.
doi:10.1371/journal.pone.0038845.t003
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an ion set. We exhausted all possible combinations with number of
ions from 1 to 8. There were
P 8
i~1
Ci
17~65,535 such ion modules.
Given a particular ion module M, let X represent its vector of
scores over the samples, and let Y represent the corresponding
vector of class labels (disease or normal). To derive a, expression
values gij were normalized to z-transformed scores zij which for
each ion i had mean m=0 and standard deviation d=1 over all
samples j.
The individual zij of each member ion in the ion module were
averaged into a combined z-score, which was designated as xj.
Many statistical methods, such as the t or Wilcoxon score, could be
used to score the relationship between X and Y. In this study, we
defined the conditional mutual information between X and Y
IX ;YDZ ðÞ ~H X,Z ðÞ zH Y,Z ðÞ {H X,Y,Z ðÞ {HZ ðÞ
Where X, Y and Z enumerate values of ion module levels,
metabolic disorders and adjust variables, respectively. H was the
entropy of the empirical probability distribution. To derive a’ from
a, activity levels were discredited into [log 2(# of samples) +1]=11
equally spaced bins [31].
Step 2: Searching for significant ion modules. To assess
the significance of the identified ion modules, we calculated the
exact permutation p-values using the function permp in R package
statmod [32]. For the random model, the class labels were
permuted 1,000 times, yielding a null distribution of mutual
information scores for each ion module; the real score of each ion
module was indexed on this null distribution. In this study, the
Figure 1. The overweight/obesity, metabolic syndrome and type 2 diabetes related ion network. A. The overweight/obesity related ion
network; B. The metabolic syndrome related ion network; C. The type 2 diabetes related ion network. The size of node represents the combined
Fisher score of significant combinations involve a specific ion, which indicates the strength of ion module in association with metabolic disorders. The
width of the edge represents the Fisher score of edge between connected ions, which indicates the possibility of forming an ion module associated
with metabolic disorders. Three ion patterns were postulated when comparing the rank of ion effect in individual and in network associated with
metabolic disorders. ‘‘Individual ion’’ was defined as the rank of ion in the network posterior to that of single ion. ‘‘Module ion’’ was defined as the
rank of ion in network prior to that of single ion. ‘‘Module-individual ion’’ was defined as the rank of ion in network equivalent to that of single ion.
doi:10.1371/journal.pone.0038845.g001
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tests with P,0.001, according to the null distributions of S.
Step 3: Identifying disease related ion network. After
obtained those ion modules that were significantly associated with
metabolic abnormalities, we identified three ion networks to
illustrate the pattern of ion cooperation. For ion x which was in k
significant ion modules, the combined score using Fisher’s method
[33,34,35] was
Scorex~{2
X k
i~1
loge(pi)
Where pi was the permutation p-value for ion module i which has
ion x. Scorex had a chi-square distribution with 2k degrees of
freedom, where k was the number of tests being combined.
Within the significant ion module, each two ions were
considered as possible edge. So each ion module was a full
connected module. All the significant ion modules formed the
candidate network. In the network, each edge had a score. For
edge between ion x and ion y, the score was
Scoree(x,y)~ScorexzScorey
To identify the maximum scored subnetwork, we used a greedy
edge expansion algorithm by growing from every locally maximal
scored edge whose score was larger than its adjacency [33]. Every
growing new edge would get a probability by a hypergeometric
distribution:
p~ P
e{1
i~0
r{i
E{i
Here E was the number of edges in the candidate network and e
was how many edges had already been included during extension.
This value was used to measure the probability to get an edge with
higher rank than r from the total E edges when we obtained the r-
rank at present step. The probability equals to 1 when all edges
were selected and there was a minimum with the increase of e. The
minimum one was used as our cutoff to terminate the growth
procedure. In this way, the most of significant subnetwork were
selected as the identified metabolic outcome related ion network.
To study the module structure of ions, the combined score of
ion set was defined as X~fx1,x2    xng using Fisher’s method
[33,34,35]
ScoreX~fx1,x2   xng~{2
X k
i~1
loge(pi)
where pi was the permutation p-value for ion module i which
included ion set X~fx1,x2    xng.
Results
Characteristics of Ion Concentrations in the Study
Population
The study population included 516 overweight/obese and 460
normal-weight participants. The mean BMI values were
27.962.6 kg/m
2 and 21.061.4 kg/m
2 for overweight/obese and
normal-weight participants, respectively (P,0.001). The preva-
lence were 40.9% (n=399) for metabolic syndrome and 12.5%
(n=122) for type 2 diabetes in the study population.
Compared with those of normal-weight subjects, overweight/
obese participants were more likely to be male, with lower
educational attainment and higher prevalence of metabolic
syndrome and type 2 diabetes (all P,0.05; Table 1). They also
exhibited higher values of waist circumference, blood pressure,
glucose, insulin, HOMA-IR, total cholesterol, LDL cholesterol,
triglycerides, CRP and IL-6, and lower HDL cholesterol
concentration (all P,0.05).
As shown in Table 2, compared to the normal groups, all
groups with obesity, metabolic syndrome or type 2 diabetes had
elevated levels of Cu, P and S, but lower Mg concentration, after
adjusting for age and sex. In addition, participants with
overweight/obesity, metabolic syndrome and type 2 diabetes also
appeared to have higher levels of Fe and Sr, Cr, Se and Sr, or Cr
and Se.
Plasma Cu and P levels were positively associated with most of
the metabolic traits listed in Table 3. In addition, plasma levels of
Ca, Cr, Mg, Re, Sb, Ti and Zn were also significantly correlated
with fasting glucose levels while concentrations of Cr, Re, S, Se
and Sr were significantly correlated with triglyceride levels.
Notably, strong positive correlations were observed between Cu
and CRP (r=0.42) and also between Cu and IL-6 (r=0.31) after
adjusting for age and sex (all P,0.001). Other ions such as P and
Sr were also significantly correlated with inflammatory markers (all
P,0.05).
Metabolic Disorders Related Ion Modules and Networks
There were 50, 60 and 38 ion modules associated with
overweight/obesity, metabolic syndrome and type 2 diabetes with
exact permutation P-value ,0.001, respectively. The number of
exact permutation is 65,535 ion modules with overweight/obesity,
metabolic syndrome and type 2 diabetes. The complete exact
permutation P value (,0.01) list of ion modules with overweight/
obesity, metabolic syndrome and type 2 diabetes were presented in
Table S5, Table S6 and Table S7.
The overweight/obesity, type 2 diabetes and metabolic
syndrome related ion networks were shown in Figure 1. The
Fisher score of 68 edges between connected ions in those three
networks were also demonstrated in Table S8, Table S9 and
Table S10. Among the 68 edges of all three networks, Cu-P
ranked in the first, suggesting the strongest connected ion pair
(Tables S8, S9, and S10). While Cu-Zn, a previously well
studied ion pair, ranked 14
th among 68 edges of overweight/
obesity network (Table S8), 17
th among 68 edges of metabolic
syndrome network (Table S9), and 19
th among 68 edges of type 2
diabetes network (Table S10).
To show the effects of highly connected ion modules, we
calculated the combined Fisher score for two ion modules and
three ion modules (Table S11). Table 4, Table 5 and Table 6
showed that two ion modules contained Cu and three ion modules
contained Cu-Zn were associated with overweight/obesity,
metabolic syndrome and type 2 diabetes (extracted from Table
S11). The Cu-P module scored the highest in all two ion modules
of Cu. While in three ion modules of Cu-Zn, the Cu-Zn-P module
scored the highest for both overweight/obesity and metabolic
syndrome, and the Cu-Zn-Mg module scored the highest for type
2 diabetes.
Postulated Ion Patterns in Association with Metabolic
Disorders
Figure 1 also showed the exact permutation P-values of single
ion with overweight/obesity, metabolic syndrome and type 2
Ionomic Profile and Metabolic Abnormalities
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significantly associated with overweight/obesity; plasma levels of
K, P, Cu, Mo and Cr were significantly associated with metabolic
syndrome; plasma levels of Cr, K, Mo, Cu and P were significantly
associated with type 2 diabetes (all P,0.05). Ranks of ions in the
networks were also displayed in Figure 1. Comparing the rank of
ion effect in individual and in network associated with metabolic
disorders, three ion patterns were postulated: (1) ‘‘Individual ion’’
was defined as the rank of ion in the network posterior to that of
single one, including K and Cr. Those ions were prone to affect
metabolic disorders in individual ways; (2) ‘‘Module ion’’ was
defined as the rank of ion in network prior to that of single ion,
which was prone to affect metabolic disorders in combination with
other ions. Fe was not significantly associated with type 2 diabetes,
but always occurred in diabetes associated ion modules; and (3)
‘‘Module-individual ion’’, in that situation ion like Cu ranked
equivalently in individual and in network associated with obesity.
Discussion
To our best knowledge, this was the first study to utilize the
novel approach of ionomics with mutual information to investigate
simultaneously single ion and multiple ions that were represented
by ion modules/networks and the associations with metabolic
abnormalities in human population. Three constructed ion
networks were found to be associated specifically with obesity,
metabolic syndrome and type 2 diabetes. Effects of ion(s) could be
postulated as ‘‘Individual ion’’, ‘‘Module ion’’ and ‘‘Module-
individual ion’’, suggesting potential associations of different ions
and/or ion modules/networks with the metabolic risks in the
Chinese population.
In this study, using ionomic approach, instead of individual ion,
we revealed not only the complicated relationships of ion-ion, ion-
phenotypes including obesity, metabolic syndrome and type 2
diabetes, but also specific ion modules/networks, which linked
with different stages in obesity related metabolic disorders.
Previously, individual role of specific ions like Fe and Zn in the
pathogenesis of metabolic disorders have been broadly investigat-
ed in cross-sectional studies, prospective studies, and even clinical
trials [1,2,7,11,36]. More recently, some of investigators have used
Mass Spectrometry and Atomic Absorption Spectroscopy to
measure multi-ions. They also compared individual ion concen-
trations between obese or diabetic cases and non-obese or non-
Table 4. Two ion module of Cu and three ion module of Cu
and Zn in overweight/obesity.
Two ion module of Cu Three ion module of Cu and Zn
Ion 1 Ion 2 Score Ion 1 Ion 2 Ion 3 Score
Cu P 428.3428 Cu Zn P 124.3576
Cu Mo 317.8027 Cu Zn Mo 82.90506
Cu Sb 303.9852 Cu Zn Sb 82.90506
Cu Cr 276.3502 Cu Zn Mg 69.08755
Cu Sn 234.8977 Cu Zn Cr 27.63502
Cu Mg 179.6276 Cu Zn Fe 27.63502
Cu Re 179.6276 Cu Zn Re 27.63502
Cu Mn 151.9926 Cu Zn S 27.63502
Cu S 124.3576 Cu Zn Se 27.63502
Cu Zn 124.3576 Cu Zn Sn 27.63502
Cu Sr 110.5401 Cu Zn Ca 13.81751
Cu Fe 96.72257 Cu Zn Sr 13.81751
Cu Ca 41.45253 Cu Zn Ti 13.81751
Cu Se 41.45253
Cu Ti 41.45253
doi:10.1371/journal.pone.0038845.t004
Table 5. Two ion module of Cu and three ion module of Cu
and Zn in metabolic syndrome.
Two ion module of Cu Three ion module of Cu and Zn
Ion 1 Ion 2 Score Ion 1 Ion 2 Ion 3 Score
Cu P 317.8027 Cu Zn P 124.3576
Cu Cr 221.0802 Cu Zn Cr 69.08755
Cu Mo 179.6276 Cu Zn Mo 69.08755
Cu Sn 165.8101 Cu Zn S 69.08755
Cu Sb 151.9926 Cu Zn Mg 41.45253
Cu Zn 138.1751 Cu Zn Re 41.45253
Cu Mg 124.3576 Cu Zn Se 41.45253
Cu Mn 124.3576 Cu Zn Sn 41.45253
Cu Re 124.3576 Cu Zn Sr 41.45253
Cu S 110.5401 Cu Zn Ca 27.63502
Cu Fe 69.08755 Cu Zn Fe 27.63502
Cu Sr 69.08755 Cu Zn Sb 27.63502
Cu Se 55.27004 Cu Zn Mn 13.81751
Cu Ca 41.45253
Cu Ti 41.45253
Cu K 27.63502
doi:10.1371/journal.pone.0038845.t005
Table 6. Two ion module of Cu and three ion module of Cu
and Zn in Type 2 diabetes.
Two ion module of Cu Three ion module of Cu and Zn
Ion 1 Ion 2 score Ion 1 Ion 2 Ion 3 Score
Cu P 221.0802 Cu Zn Mg 55.27004
Cu Cr 151.9926 Cu Zn P 55.27004
Cu Sn 138.1751 Cu Zn Ca 41.45253
Cu Mo 96.72257 Cu Zn Cr 41.45253
Cu Sr 96.72257 Cu Zn S 41.45253
Cu Mg 82.90506 Cu Zn Sb 41.45253
Cu Mn 82.90506 Cu Zn Sn 41.45253
Cu S 82.90506 Cu Zn Mo 27.63502
Cu Sb 82.90506 Cu Zn Fe 13.81751
Cu Zn 82.90506 Cu Zn Mn 13.81751
Cu Fe 69.08755 Cu Zn Re 13.81751
Cu Re 69.08755 Cu Zn Se 13.81751
Cu Ca 41.45253 Cu Zn Sr 13.81751
Cu Se 41.45253
Cu K 27.63502
Cu Ti 13.81751
doi:10.1371/journal.pone.0038845.t006
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patients with and without metabolic alterations [38]. However, it
still remains unknown regarding the cluster effect of ion modules/
networks on obesity and related metabolic disorders. Indeed, itwas
noticed previously that multiple ions may interact synergistically or
antagonistically and consequently influence overall ion homeostasis
[13,14]. Moreover, a specific ion when presented alone or in a
combination with other ion(s) may have different impact on metabolic
outcomes. Therefore, although the ionomic approach provides a great
opportunity to study the global effect of multi-ions, it also becomes a
big challenge to elucidate complicated relationships and mechanistic
linking between multiple ions and metabolic disorders.
To better explore the complex associations between ionomic
profile and different stages of metabolic abnormalities in population
level, we employed a novel machine learning data processing
approach,namelymutual information inthepresent study.In many
prior studies, paired Student’s t test, Mann–Whitney U-test or
ANOVA have been frequently used to compare ion concentrations
in different groups [37,38,39,40,41,42]. One study also adopted
PCA analysis to explore relationships of metals/metalloids with
clinical parameters [42]. Although PCA analysis was admittedly
useful to construct patterns from high dimension data, the linear
dependence nature of this approach might lose information [21]
and could not describe adequately for the non-linear dependences
resulting from synergistic or antagonistic interactions within ion
modules/networks [13,14]. On the other hand, the mutual
information that measures the general dependence including both
linearand non-lineardependences[24,25], mayallowus todiscover
specific ionomic fingerprints attributing to different metabolic
outcomes. Indeed, with this approach, three specific ion networks
were constructed to reflect stages of obesity, metabolic syndrome
and type 2 diabetes. Certainly, more prospective studies are merited
to confirm our findings.
Another noteworthy finding of this study is that we characterized
ion modules/networks as ‘‘Individual ion’’, ‘‘Module ion’’ and
‘‘Module-individual ion’’, implicating that the role of a specific ion
in the pathogenesis of metabolic disorders may vary according to
whethersingleionorionsinmodules/networkswereincludedinthe
data analysis. For instance, Fe per se was not significantly associated
with type 2 diabetes, while it ranked 3
rd in the ion networks
associated with type 2 diabetes. Previously, we have observed that
high Fe load, indicated by elevated circulating ferritin, was
significantly associated with type 2 diabetes in Chinese population
[43]. Prospective studies conducted in Western populations also
demonstrated a predictive role of ferritin level in the onset of type 2
diabetes [1,2]. The discrepancy between the current study and
earlier studies might be due to the fact that Fe was used as an ion
form rather than its protein biomarker like ferritin. However, given
the nature of complicating interactions between Fe and other ions,
such as Cu and Zn [13,14], it needs to be clarified whether Fe in a
specific ion module might act additively or synergistically with other
ions to influence overall risk of type 2 diabetes.
Another interesting phenomenon was that both Cu and P were
always ranked in the top two positions among 17 ions included in
the three specific ion networks related to obesity, metabolic
syndrome and type 2 diabetes, implicating potential associations of
Cu and P with these metabolic disorders. Indeed, increased level of
Cu was observed in diabetic patients [44]; while administration of
Cu chelating reduced insulin resistance and also alleviated glucose
intolerance in diabetic db/db mice [45]. In addition, high serum P
level was reported to be positively associated with hypercholester-
olemia and subclinical atherosclerosis [46], and might predict
cardiovascular mortality in type 2 diabetes [47]. Besides its role as
a single mineral, Cu also exhibits multiple mechanisms in
regulating ion homeostasis under physical and pathological
conditions. For examples, Cu could interact with Fe in the
processes of absorption, transportation and metabolism in multiple
tissues and cells, which may be modified by the amount and ratio
of each ions and likewise the overall interaction might also
influence whole body Cu-Fe homeostasis and related health or
disease conditions [13]. Moreover, the Cu-Mo interaction was also
suggested as a reaction between thiomolybdate and Cu by studies
in animal model and human tissue [48,49]. Significantly different
levels of Cu-Zn-superoxide dismutase (CuZn-SOD), a form of Cu
and Zn, were also reported between obese and non-obese controls
[50]. In addition, the Cu/Zn ratio was reported to be associated
with multiple abnormalities and diseases [51,52,53,54,55]. Re-
garding to P, the co-joint effect of P and Ca on increasing total
mortality of middle-aged men was reported in a Sweden cohort
[56], in line with adverse role of P contained ion modules in
metabolic disorders.
Although current study could not provide direct evidence for
the mechanistic link between plasma ions and metabolic disorders,
there are plausible explanations. First, several measured ions such
as Fe, Cu, Cr, Zn and Se were previously reported to be involved
in the induction or defense of oxidative stress [57,58]. Second,
genetic variants of several ions were shown to be associated with
diabetes. For instance, TMPRSS6 variants were significantly
associated with ferritin and risk of type 2 diabetes in Chinese
[59], while ferritin itself was an independent risk factor for
metabolic syndrome and type 2 diabetes [1,2,43]. However, we
observed significantly lower intake of multiple ions in subjects with
metabolic disorders (Zn, Se, Mg, Ca, P and K in overweight/
obesity, Zn, Ca and P in metabolic syndrome, as well as Mg, Ca, P
and K in diabetes, data not shown) in comparison with their
normal counterparts, although the influence of intake levels on
plasma ion concentrations remains unclear. Moreover, the strong
correlations between plasma Cu levels and inflammatory markers
suggest that the association between Cu levels and metabolic
disorders might be partially explained by inflammatory status [60].
Therefore, the complicated network and potential mechanistic
linking between multiple ions and metabolic disorders merit
further investigation.
Overall, by using the novel approach of the ionomics strategy
and the information theory, we observed potential links between
multiple ions and metabolic abnormalities. However, since our
findings were mainly driven by statistical analysis, future biological
and mechanistic studies are needed to confirm the observed
associations. Moreover, the cross-sectional nature of this study also
prevents us from establishing causal relation. Meanwhile, the case-
control design might also limit our findings to be generalized in
general populations. Certainly, more prospective studies are
merited in this regards. Nonetheless, our study attempts to use a
different methodology to explore the associations between multiple
ions and metabolic disorders in a large-scale population based
study.
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